Evidence map›Paper›PMID 29987223›Full record

ReviewNanomaterials (Basel, Switzerland)2018

Lanthanide-Doped Upconversion Nanocarriers for Drug and Gene Delivery.

Gibok Lee, Yong Il Park

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Bioinformation · 2025
    Article
  6. Light-responsive biomaterials for ocular drug delivery.Drug delivery and translational research · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. UVA-Triggered Drug Release and Photo-Protection of Skin.Frontiers in cell and developmental biology · 2021
    Review
  16. Review
  17. Spiropyran-Based Drug Delivery Systems.Frontiers in chemistry · 2021
    Review
  18. Synthesis, Optical Properties, and Sensing Applications of LaFNanomaterials (Basel, Switzerland) · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gibok LeeSchool of Chemical Engineering, Chonnam National University, Gwangju 61186, Korea. 188608@jnu.ac.kr.ORCID 0000-0002-5039-2028
Yong Il ParkSchool of Chemical Engineering, Chonnam National University, Gwangju 61186, Korea. ypark@jnu.ac.kr.ORCID 0000-0003-3167-4908

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compared to traditional cancer treatments, drug/gene delivery is an advanced, safe, and efficient method. Nanoparticles are widely used as nanocarriers in a drug/gene delivery system due to their long circulation time and low multi-drug resistance. In particular, lanthanide-doped upconversion nanoparticles (UCNPs) that can emit UV and visible light by near-infrared (NIR) upconversion demonstrated more efficient and safer drug/gene delivery. Because of the low penetration depth of UV and visible light, a photoinduced reaction such as photocleavage or photoisomerization has proven restrictive. However, NIR light has high tissue penetration depth and stimulates the photoinduced reaction through UV and visible emissions from lanthanide-doped UCNPs. This review discusses the optical properties of UCNPs that are useful in bioapplications and drug/gene delivery systems using the UCNPs as a photoreaction inducer.

Indexed as

drug deliverygene deliverynanocarriersphotolysisupconversion nanoparticles

Identifiers

PMID29987223
PMCPMC6071191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.